Point in Time census offers glimpse into suburban homelessness
After years of conducting annual counts to gauge how many people in the area are experiencing homelessness, the team from La Grange-based BEDS Plus have a good idea where to look.
'We come up with hot spots, where we've either met with people in the past or areas where we think people might be,' said Zac Catrambone, BEDS Plus manager of street outreach.
Those hot spots include hospital emergency rooms, libraries and gas stations, as well as less obvious places, Catrambone said.
'Twenty-four hour laundromats, park district buildings, or parking garages, like the La Grange Parking Garage on the third floor,' he listed. 'In the winter they rope off that top deck and it's heated up there. (If) they're not able to go to any shelter, or they don't want to go to a shelter … it's a place where they can get out of the elements.'
Catrambone was advising volunteers taking part in the annual Point in Time Count on Jan. 29. Sponsored by the Alliance to End Homelessness, the effort serves as a 'homeless census,' on both a national and a local level, giving various organizations solid information on how many people in the area are experiencing homelessness and where they are.
'The Chicagoland area started doing this in about 2013,' Catrambone said as volunteers were assigned to areas throughout the west and southwest suburbs. 'Our areas that we are responsible for tonight are basically La Grange, La Grange Park, McCook, Hodgkins, then we go down to Oak Lawn, Chicago Ridge, Bridgeview, Summit, Justice … all the way down to Orland Park.'
Catrambone said the amount of people contacted during the Point in Time count has varied from year to year, 'especially during years where it's really cold, people tend to go to warning centers and might not be found.'
While the BEDS Plus home base is in La Grange, the organizing point this year was at the nonprofit's Linda Sokol Francis Summit Service Center at 7666 W. 63rd Street in nearby Summit, Illinois.
Opened in 2023, the center in Summit has 18 beds and provides acute and post-acute medical care for homeless people who are too ill or vulnerable to recover on the street, but don't qualify for further hospitalization or nursing home care.
Besides the La Grange facility and the Summit Service Center, Beds Plus also has a triage shelter on Cicero Avenue in Chicago, and provides temporary housing at the American Inn in Countryside.
The group also has several 'bridge units' that are leased in the agency's name where people can stay until they are matched to a housing program. Catrambone said that these units were typically used for families and people fleeing domestic violence.
BEDS Plus had 22 volunteers out for the Jan. 29 count, including four people with the lived experience of being housing challenged.
'It was a good event last night,' Catrambone said the following day.
The volunteers began canvassing their territories around 6:45 p.m. and finished around midnight, making contact with eight people and interviewing four of them, who BEDS Plus representatives will follow up with.
Point in Time also provided an opportunity to check in with people who've been on the streets for a while, including one person near La Grange Village Hall who 'we know pretty well.'
'The person at Village Hall was usually in the parking structure, but was outside today, ' he said.
Once BEDS Plus is able to make contact, they can offer help.
'I do housing paperwork for them and try and connect them with programs throughout suburban Cook County,' said Rick Maltese, who's been with BEDS Plus for four years as an assessor. 'So the paperwork gets uploaded into our system and they become eligible to get the program matches.'
Volunteer Jack Rudzinski said the importance of gauging the extent of homelessness is vital because it illustrates the need for funding and programs nationwide.
'The point is to determine funding for the next year's homeless programs,' he said. 'Hey, this is how many homeless we have, and this is why we need to allocate funding. So it's super important to have people out here doing this, as many as we can out canvassing, looking for folks. Not only are we helping the folks that we find tonight, but we're also helping the entire country by making the government aware of how widespread the problem is, and how much needs to be done.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
5 hours ago
- Indianapolis Star
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak
A Maryland food company has recalled specific salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. TGD Cuts, LLC of Jessup, Maryland, is recalling some tub and tray products because they contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc., which have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration (FDA). The products had use-by dates ranging from May 20 to May 28 and are unlikely to be in stores or being used. No illnesses have been reported in connection with the products, the FDA said. Egg recall: Brown eggs sold at some Walmart stores have salmonella risk The initial May 19 recall involved cucumbers sold directly to consumers at Bednar's Farm Fresh Market, according to notices published May 19 by the Centers for Disease Control and Prevention (CDC) and the FDA. Subsequent recalls have been announced by grocers such as Harris Teeter, Kroger and Walmart for repackaged cucumbers for resale under different brand names or those used in ready-to-eat products, including vegetable trays and salads. The cucumbers, distributed by Fresh Start Produce Sales of Delray, Florida, also led to Target recalling individual cucumbers on May 30, specifically cucumber two-packs and various prepared foods products. In addition to the growing cucumber-related recall, other products have been recalled recently for potential salmonella contamination. The FDA on May 28 upgraded a recall of tomatoes distributed in three southern states to a Class I recall, meaning consumption of the food could cause serious health complications or lead to death. Then, on June 6, the CDC and FDA linked brown eggs sold in nine states – including at some Walmart stores – to an ongoing Salmonella Enteritidis outbreak, in which 79 people have been sickened and at least 21 hospitalized. Customers who purchased any products from TGD Cuts should get rid of them or return them for a full refund. Here is the list of products recalled due to a possible salmonella risk. Salmonella poisoning causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms, which include diarrhea, fever and stomach cramps, will usually occur six hours to six days after exposure and may last up to seven days. Symptoms from severe infections may include aches, headaches, elevated fever, lethargy, rashes, and blood in urine or stool. Mike Snider is a reporter on USA TODAY's Trending team. You can follow him on Threads, Bluesky, X and email him at mikegsnider & @ & @mikesnider & msnider@
Boston Globe
8 hours ago
- Boston Globe
Will Trump's policies kill Massachusetts' life sciences leadership?
Advertisement Although the industry is centered in eastern Massachusetts, there's a statewide benefit from all the tax dollars those businesses and workers pay. Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up In all, Massachusetts organizations — including universities, research institutes, and hospitals — received $3.5 billion in funding from the National Institutes of Health. Massachusetts-headquartered companies raised $3.26 billion in venture capital funding. Among all drugs in the development pipeline in the United States, 15 percent were being made by companies headquartered in Massachusetts. But actions taken by President Trump and his administration — cutting funding for scientific research and universities, flirting with tariffs, fanning skepticism about vaccines — threaten to devastate the ecosystem. Today, the industry is at a precipice, and uncertainty abounds. Some companies are already feeling the pinch of terminated federal grants, while others are anxious about what might come. Taken together, Trump's policies could force some companies and scientists to take their money, talents, and products overseas. Advertisement Christopher Locher, CEO of Lowell-based Versatope Therapeutics, which develops a platform to deliver vaccines and therapeutics, said he worries the Greater Boston life sciences ecosystem is 'being flushed down the toilet.' For example, Trump is Trump's funding cuts are already having a large impact on some local companies. Part of the problem is the Trump administration isn't only cutting funding, but it's picking which technologies to fund — in some cases apparently based on politics more than science. Take flu vaccines. The Trump administration recently announced a $500 million campaign to fund the development of a universal flu vaccine, which doesn't require annual updates, using technology being worked on But simultaneously, he cut funding for other work on a universal flu vaccine. Versatope Therapeutics got $14 million in NIH funding and spent five years developing a universal flu vaccine. It had approval from the US Food and Drug Administration to begin clinical trials when Trump terminated the contract's remaining $8 million, with the reason given being 'convenience,' Locher said. Trump also Advertisement Company executives say decisions by Trump officials to disinvest in vaccine-related technology — and concerns about whether government will approve new technology — means it's nearly impossible to find private investment funding to replace lost federal dollars. 'We're faced with bankruptcy in the very near future,' Locher said. Ironically, given Trump's stated commitment to bringing businesses back to the United States, one potential option Locher is eyeing is opening a subsidiary abroad. Conducting clinical trials would be cheaper in another country, whether in Europe, Australia, or China, Locher said, and some countries are offering financial incentives to American companies to relocate. Companies also face a potential workforce brain drain. There have been MassBio officials said China has less rigorous — but faster — safety and research protocols than the US. Australia allows a faster timeline for clinical trials. If regulatory approval of medicines is held up because the FDA is understaffed, companies may seek European regulatory approval instead. The loss of talent to foreign countries will be compounded if the pipeline of local university graduates dries up. One draw for life sciences companies to Boston/Cambridge is the presence of elite schools like Harvard and MIT, with their potential for faculty collaboration and skilled graduates. Advertisement Trump is trying to Chip Clark, CEO at Vibrant Biomedicines in Cambridge, said cuts to university research funding both 'shrink the pipeline of great ideas' that form the basis for many biotech startups and translate to fewer available scientists. Clark said the administration's policies 'seem like a deliberate attempt to try to cede scientific leadership to Europe and Japan and Korea and China. ... They will be delighted to capitalize on our talent, technology, and investment capital to make their robust biotech sectors grow and ultimately compete successfully against the US industry,' he said. Don Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, said he has postdocs with US visas applying for jobs in Europe, and others who were accepted to work at Harvard but are going elsewhere. 'The fact that places like Harvard and MIT and American universities are magnets for the best and brightest from around the world is what's driven our technology economy and certainly the Boston/Cambridge ecosystem,' Ingber said. 'With this uncertainty, I fear we'll lose a generation.' Ingber, who was forced to stop work on two government-funded projects on drugs designed to prevent injury from radiation exposure, compared administration policies to 'eating seed corn' needed to grow crops. Advertisement Trump's vendetta will undermine one of the most vibrant state economies in the country and set back American science by years. And it's not just eastern Massachusetts that will pay a price; the entire country will. As Ingber noted, it might take years to see the impact of medicines or technologies that aren't developed because of these shortsighted cuts. Editorials represent the views of the Boston Globe Editorial Board. Follow us
Epoch Times
20 hours ago
- Epoch Times
Nasal, Baby Teething Swabs Recalled Nationwide Over Microbial Contamination Fears
New Jersey-based Church & Dwight Co., Inc. is recalling three nasal and baby teething swab products due to potential fungal contamination in the cotton swab components, the company said in a June 6 The recall is applicable to three products: Zicam Cold Remedy Nasal Swabs designed to tackle the common cold, Zicam Nasal AllClear Swabs used for cleansing, and Orajel Baby Teething Swabs aimed at soothing teething discomfort among toddlers and infants.
